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Abstract
The sub-chronic toxicity of Tonica, an aqueous herbal haematinic prepared from the stem barks of
Khaya senegalensis, Mitragyna stipulosa and Kigelia africana, was investigated in male Sprague-Dawley rats at
28, 280 and 560 mg kg-1 day-1, representing the normal human dose, 10x and 20x that dose, respectively for 6
weeks. The growth rate of animals over the period of treatment and certain serum biochemical and
haematological indices as well as urinalysis and weight of selected organs at termination, were determined.
Results show that the extract did not affect the weight gain of the animals with time or the mean wet weights of
selected organs. Although there were slight but insignificant (p>0.05) elevations in WBC (16-27%) and PLT (8-
11%) counts in Tonica-treated animals compared to controls at 10x and 20x the normal dose, most serum
biochemical, haematological and urinalysis data indicated no significant differences (p>0.05) between tests and
control rats. There were also no changes in the morphology of liver, kidney, lung and heart tissues as a result of
Tonica treatment. These findings suggest that Tonica is safe at the dosage regimens administered to the animals
in this study, and there appears to be no overt organ specific toxicity associated with it.
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Introduction
There is growing concern worldwide about the efficacy, safety, quality, availability, preservation and
further development of plant medicines for health care delivery. Although many traditional medicines have
promising potentials, many are untested and their use not monitored. As a result, knowledge of their potential
side effects is limited making the identification of the safe and most effective therapies and the promotion of
their rational use very difficult (WHO, 2002).
Tonica is an aqueous herbal haematinic prepared from the stem barks of Khaya senegalensis, Mitragyna
stipulosa and Kigelia africana. K. senegalensis belongs to the Mahogany family (Meliaceae). Studies have
shown that aqueous and ethanolic extracts of the stem bark of K. senegalensis have anti-helminthic, anti-
proliferative, gastrointestinal motility and anti-inflammatory activities (Ademola et al., 2004; Egesie et al., 2004;
Androulakis et al., 2006). However, the ethanolic extract of K. senegalensis administered to rats at 2 mg kg -1
body weight for 6 and 18 days showed signs of renal toxicity (Adebayo et al., 2003).
M. stipulosa belongs to the Madder family (Rubiaceae). It is widely used for the treatment of
inflammation, hypertension, headache, rheumatism, gonorrhea and broncho-pulmonary disease. The methanolic
extract of M. stipulosa has been demonstrated to possess anti-inflammatory activity, and that alkaloids and
kaemferol derivative, may be responsible for its anti-inflammatory properties (Dongmo et al., 2003).
K. africana belongs to the bat flower family (Bignoniaceae). Generally, the stem bark of Kigelia is
noted to contain iridoid and its derivatives, napthaquinones, monoterpenoids, isocourmarins, lignans, sterols and
flavonoids (http://www.healthbells.co.za//kegelia Tech.htm.). The aqueous extract and two major iridoids
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showed significant antimicrobial activity, validating the anecdotal use of the plant in traditional medicine as a
natural antibacterial and antifungal agent (Akunyili et al., 1991). In vitro studies demonstrated that four
naphthoquinoids from Kigelia root bark showed anti-malarial activity against chloroquine-sensitive (T9-96) and
resistant (KI) Plasmodium falciparum strains (Weiss et al., 2000).
Despite the extensive use of these plants there is no evidence of their use either singly or in
combinations for the treatment of anaemia, making Tonica a novel natural product for the treatment of anaemia.
Recent clinical evaluation of Tonica at the Centre for Scientific Research into Plant Medicine (CSRPM)
indicated that it is an effective and safe haematinic for use in humans (Adusi-Poku et al., 2008).
The pre-clinical safety evaluation of new medicinal products, involving the determination of their
effects on certain haematological, blood chemistry and histopathological parameters as indices of organ specific
toxicity, is a pre-requisite for their clinical studies and subsequent registration by drug-regulatory agencies like
the Food and Drugs Board (FDB) of Ghana, Committee on Safety of Medicines (CSM) of the UK and the Food
and Drugs Administration (FDA) of the USA. Hence the pre-clinical safety evaluation of Tonica in Sprague-
Dawley rats in our laboratory prior to its evaluation in humans is presented in this paper.
Materials and Methods
Reagents and Chemicals
Test kits: aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamylaminotransferase 
(GGT), bilirubin (direct and total), albumin, creatinine, urea, creatinine kinase (CK-MB) were purchased from
Cypress Diagnostics (Belgium). Urine test strips (UroColorTM 10) were supplied by Standard Diagnostics Inc.
(Kyonggi-do, Korea). Pentobarbital was obtained from Sigma Chemical Co (St. Louis, MO, USA). All other
chemicals were purchased in the purest form available from British Drug Houses (BDH) Ltd. (Poole, UK).
Preparation of Tonica Extract
Tonica was prepared from the stem barks of three different plant species: Khaya senegalensis,
Mitragyna stipulosa and Kigelia africana (CSRPM voucher specimen numbers 175, 233 and 306, respectively)
in kilogram quantities (8:4:2) in 110 litres of sterile distilled water. This was boiled for one hour, cooled to room
temperature, and re-boiled for another hour. The extract was sieved and freeze-dried (Heto Power Dry LL 3000,
Denmark) to give a dry extract yield of 72000 mg kg-1 plant raw material mixture (7.2% w/w) and stored in a
cool dry place. The extract was reconstituted in sterilized distilled water before administration to animals.
Animals
Male Sprague-Dawley rats (200-250 g) were obtained from the Animal Unit of the CSRPM, Mampong-
Akuapem, in the Eastern Region of Ghana. The animals were fed ad libitum on powdered feed obtained from
Ghana Agro Food Company (GAFCO), Tema, Ghana. They were allowed free access to sterile distilled water.
Studies were conducted in accordance with internationally accepted principles for laboratory animal use and
care.
Treatment of Animals
Four groups of six rats each were kept in four separate cages. Group one was kept as control and
received sterilized distilled water for six weeks. Groups two, three and four were treated with 28, 280 and 560
mg kg -1 body weight, respectively of Tonica daily by oral gavage for six weeks. The animals in each group were
weighed on day zero (baseline) and weekly thereafter.
Histology
At the termination of treatment, four rats each from control and Tonica-treated groups were euthanized
by cervical dislocation and the heart, lungs, liver, kidney and spleen were excised and weighed by a Mettler
balance (Mettler Toledo, Switzerland). With the exception of the spleen, the other four organs were fixed in
10% formaldehyde and dehydrated with a progressively increasing concentration of alcohol. The tissues were
cleared with chloroform and impregnated with paraffin wax. Sections were cut, stained with haematoxylin and
eosin and mounted on slides for light microscopic examinations. Tissue sections of the four organs of four other
rats at baseline were also prepared (Baker and Silverstone, 1985).
Martey et al., Afr. J. Trad. CAM (2010) 7 (3): 231 - 240 233
Urinalysis
Urine samples of the control and Tonica-treated rats produced as a result of involuntary discharges were
collected on clean ceramic tiles at baseline and at termination of treatment and analysis of urine for glucose,
bilirubin, ketones, specific gravity, pH, proteins urobilinogen, nitrate, blood and leukocytes was done using urine
reagent strips (UroColorTM 10, Standard Diagnostic Inc., Korea).
Blood Sampling
Blood samples of control and Tonica-treated rats were obtained by tail bleeding, at baseline and at
termination of treatment, into Eppendorf tubes without anticoagulant, centrifuged at 4000 x g for 5 min (Denley
BS 400, England) and serum stored at -40ºC for biochemical analyses. Other blood samples were collected into
separate tubes pre-coated with tri-sodium citrate (Westergreen E.S.R, UK) for haematological analysis within 24
hrs.
Serum Biochemical Analysis
Serum ALT, AST, GGT, total and direct bilirubin, albumin, CK-MB, creatinine and urea levels of
samples of control and Tonica-treated rats were determined using protocols from Cypress diagnostic kits
(Belgium) with a semi-automated blood chemistry analyzer; photometer 4040 ( Robert Riele G & Cole-2000,
Germany).
Haematological Analysis
Red blood cell (RBC) counts, mean cell volume (MCV), haematocrit (HCT), mean corpuscular
haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), red cell distribution width
(RDW), white blood cell (WBC) counts, haemoglobin (Hb), platelet counts (PLT) mean platelet volume (MPV),
Platelet distribution width (PDW) and lymphocytes (LYMPH) of control and Tonica-treated animal blood
samples were determined with Haema-screen 13 (Hospitex Diagnostics, Italy) in accordance with established
protocol. The equipment is computerized to automatically determine and display the above hematological
profile for each blood sample.
Statistical Analysis
One-way analysis of variance (ANOVA) and independent sample t-Test was conducted between control
and test to determine statistical significance. The 5% level of probability was used as criterion of significance in
all instances. All statistical tests were performed with SPSS statistical software version 11.0
Results
Changes in Rat Body and Organ Weights
Figure 1 shows a graphical representation of the percentage change in body weight following treatment
of rats with Tonica extract. There were significant increases (p< 0.05) in body weight over the experimental
period for all treatment groups. The slight reductions in growth between test and control groups were
insignificant (p>0.05) and not dose-dependent. Table 1 shows the effect of Tonica on mean organ wet weights
expressed as percentage of body weight at termination of treatment. There were insignificant differences
(p>0.05) in the relative weights of the heart, lungs, liver, kidney and spleen between control and Tonica-treated
animals.
Histology
The effect of Tonica extract on the morphology of the rat heart, kidney, liver and lungs at termination
are represented in Figures 2-5 (see legends of figures). Results showed no significant morphological changes in
cardiac tissue (Figures 2 a-d), glomerular and renal tubular areas of the kidney (Figures 3 a-d), and the liver
(Figures 5 a-d) between control and Tonica-treated animals. The lungs also did not show any significant
changes in Clara and alveolar cells as well as the bronchiolar epithelial lining between Tonica-treated and
control animals (Figures 4 a-d).
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Table 1: Mean Organs Wet Weights at Termination of Treatment
Organ weight /body weight ratio
(%)
Treatment group
Tonica
Organ Control
28
(mg kg -1)
280
(mg kg -1)
560
(mg kg -1)
Heart 0.30 ± 0 .02 0.33 ± 0.01 0.30 ± 0.03 0.32 ± 0.01
Lungs 0.51 ± 0.05 0.65 ± 0.13 0.51 ± 0.01 0.48 ± 0.01
Liver 3.09 ± 0.06 3.11 ± 0.42 3.38 ± 0.02 3.42 ± 0.10
Kidney 0.53 ± 0.05 0.57 ± 0.04 0.59 ± 0.02 0.65 ± 0.02
Spleen 0.22 ± 0.01 0.19 ± 0.02 0.21 ± 0.01 0.19 ± 0.01
Results are means ± SEM of n = 6
Table 2: Urine Parameters at Termination of Treatment a
Treatment group
Tonica
Parameter
Control
28
(mg kg -1)
280
(mg kg -1)
560
(mg kg -1)
Urobilinogen
(mg dL-1) N N N N
Glucose
(mg dL-1) – – – –
Bilirubin
(mg dL -1) – – – –
Ketones
(mg dL -1) ± ± ± ±
Density
(g mL -1) 1.03 1.03 1.03 1.03
Blood
(RBC µL -1) – – – –
pH 6.83 6.33 7.00 6.67
Protein
(g L -1) + + + +
Nitrite – – – –
Leukocytes
(WBC µL -1) – – – –
Figures represent means of 6 determinations. (–): Absent; (N): Normal; (±): Trace;
(+): Positive. a Baseline values of treatment groups were not different from controls at termination of treatment
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Table 3: Serum Biochemical Data at Termination of Treatment a
Treatment group
Tonica
Parameter Control
28
mg kg -1
280
mg kg -1
560
mg kg -1
AST
(U L -1) 46.0 ± 1.41 47.0 ± 5.37 44.3 ± 4.68 48.6 ± 5.66
ALT
(U L -1) 26.2 ± 1.59 24.2 ± 1.16 26.2 ± 4.67 28.3 ± 2.29
GGT
(IU L -1) 1.54 ± 0.19 1.51 ± 0.20 1.39 ± 0.31 1.42 ± 0.34
Total bilirubin
(µmol L -1) 2.12 ± 0.47 2.50 ± 0.62 1.94 ± 0.33 2.64 ± 0.89
Direct bilirubin
(µmol L -1) 0.72 ± 0.12 0.64 ± 0.27 0.70 ± 0.20 0.86 ± 0.23
Urea
(mmol L -1) 7.99 ± 0.40 8.04 ± 0.36 7.79 ± 0.46 6.26 ± 0.20
Creatinine
(µmol L -1) 54.8 ± 2.75 53.2 ± 2.46 70.6 ± 4.02 65.6 ± 2.48
CK-MB
( U L -1) 416 ± 129 331 ± 40.5 390 ± 42.6 362 ± 16.9
Albumin
(g L -1) 57.2 ± 5.47 57.4 ± 4.46 55.6 ± 6.15 53.8± 5.47
Results are means ± SEM of n = 6. a Baseline values of treatment groups were not different from controls at
termination of treatment.
Table 4: Haematological Parameters at Termination of Treatment a
Treatment group
Tonica
Parameter Control
28
(mg kg -1)
280
(mg kg -1)
560
(mg kg -1)
RBC
(x106 µL -1 ) 8.48 ± 1.00 8.38 ± 0.90 8.14 ± 1.04 9.02 ± 1.15
MCV
(µ3 ) 64.4 ± 0.81 65.4± 0.93 61.2 ± 2.35 64.8 ± 2.56
HCT
(%) 58.9 ± 3.06 61.1 ± 1.08 59.8 ± 2.54 58.2 ± 7.40
MCH
(pg) 20.5 ± 2.05 20.8 ± 1.44 18.9 ± 0.76 18.1 ± 1.48
MCHC
(g dL -1) 35.7 ± 6.75 32.0 ± 2.82 30.9 ± 1.17 28.2 ± 2.45
RDW
(%) 29.3 ± 2.20 28.9 ± 0.93 28.1 ± 2.04 30.7 ± 1.87
WBC
( x103 µL -1 ) 11.9 ± 1.57 11.1 ± 1.56 13.8 ± 1.68 15.1 ± 1.22
Hb
( g/l ) 16.7 ± 0.87 16.9 ± 1.11 15.1 ± 1.56 15.7 ± 0.84
PLT
( x103 µL -1 ) 762 ± 200 761 ± 52.6 846 ± 36.1 814 ± 29.3
MPV
(µ3 ) 11.0 ± 0.59 10.3 ± 0.43 10.7 ± 0.56 10.6 ± 0.20
PCT
(%) 1.21 ± 0.29 0.79 ± 0.09 1.45 ± 0.44 0.91 ± 0.13
PDW
(%) 26.2 ± 2.33 27.9 ± 4.71 25.1 ± 1.39 23.6 ± 0.37
LYMPH
(%) 96.4 ± 1.71 96.9 ± 1.60 98.0 ± 1.39 99.0 ± 0.44
Results are means ± SEM of n = 6. a Baseline values of treatment groups were not different from controls at
termination of treatment
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Figure 1: Percentage changes in mean body weight of rats with duration of Tonica treatment. Each point
represent mean ± SEM (n = 6). For details of treatment regimen, see “Materials and Methods”
Figure 2: Histological appearance of the heart of control animals (a) and animals treated with normal dose of Tonica
extract: 28 mg kg -1 (b), 10x the normal dose: 280 mg kg -1 (c) and 20x the normal dose: 560 mg kg -1 (d) at
termination showing no differences in morphology of cardiac tissue. Magnification: x66.
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Figure 3: Histological appearance of the kidney of control animals (a) and animals treated with normal dose of
Tonica extract: 28 mg kg -1(b), 10x the normal dose: 280 mg kg -1(c) and 20x the normal dose: 560 mg
kg -1(d) at termination showing no differences in tubular (1) and glomerular (2) areas compared to
control. Magnification: x66.
Figure 4: Histological appearance of the lung of control animals (a) and animals treated with normal
dose of Tonica extract: 28 mg kg -1(b), 10x the normal dose: 280 mg kg -1(c) and 20x the normal
dose: 560 mg kg -1(d) at termination showing normal alveolar areas (1) and Clara cells (2) lining a
normal bronchiolar epithelial wall (3). Magnification: x66.
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Figure 5: Histological appearance of the liver of control animals (a) and animals treated with normal dose of
Tonica extract: 28 mg kg -1(b), 10x the normal dose: 280 mg kg -1(c) and 20x the normal dose: 560 mg
kg -1(d) at termination showing no differences in appearance of hepatocytes (1) and interstitial spaces
(2) compared to control. Magnification: x132.
Urinalysis Data
Dipstick urinalysis data of control and Tonica-treated animals at termination of treatment is shown in
the Table 2. Results indicated that there were no significant differences in urine blood, bilirubin, urobilinogen,
proteins, ketones, glucose, nitrite, leucocytes, pH and specific gravity between Tonica-treated and control
animals. Baseline values for each treatment group (results not shown) were similar to control values at
termination.
Serum Biochemical and Haematological Data
The effect of Tonica treatment of rats on some serum biochemical and haematological parameters at
termination of treatment are presented in Tables 3 and 4. No significant differences (p>0.05) were observed in
serum levels of ALT, GGT, albumin, AST, total and direct bilirubin, urea, creatinine and CK-MB and the
haematological indices measured between Tonica-treated animals and controls. Baseline values for each
treatment group (results not shown) were similar to control values at termination.
Discussion
Anaemia is the principal nutritional problem in the world and affects mostly children and pregnant
women in developing countries. According to the WHO, nutritional anaemia is a state in which the haemoglobin
concentration of the blood is lower than the levels considered normal for the age, gender and physiological state
and altitude as a consequence of the shortage of essential nutrients, independent of the cause of this deficiency
(De Mayer et al., 1989; Coutinho et al., 2005).
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Tonica is a novel aqueous herbal haematinic that has been used by the CSRPM for over 20 years at its
clinic for the treatment of anaemia in pregnant women and anaemia due to other causes. Recent studies have
shown that Tonica administration to patients over a 14-day period caused the elevation of blood Hb levels at a
rate of 1.66 g dL -1 per week which is 66% faster than most known allopathic haematinics (Hope et al., 1999;
Adusi-Poku et al., 2008).
Haematological studies in the animals indicated that the Toncia extract did not cause any significant
changes in haematological indices (Table 4). The WBC and LYMP counts were slightly but insignificantly
increased an indication that it may enhance, to some degree, the defences of the body to fight infections or
cellular injury and may be of benefit to HIV/AIDS patients whose defences are normally compromised. The
absence of any change in Hb levels on Tonica treatment in animals is at variance with the 1.66 g dL -1 increase
per week found in humans (Adusi-Poku et al., 2008). This suggests species differences in the effect of Tonica
on Hb levels, and that the rat may not be a good animal model to study the efficacy of Tonica as a haematinic.
Tonica does not appear to directly damage blood cells or indirectly cause damage to the bone marrow.
The absence of any morphological changes in selected organs like the liver, kidney and heart (Figures 2,
3 and 5), which are corroborated by urinalysis and serum creatinine and urea data for renal function, serum AST,
ALT, GGT, bilirubin and albumin for liver function and serum CK-MM for the cardiac function (Table 3), are
indicative of the fact that Tonica did not adversely affect any of these three organs. Despite the observation that
K. senegalensis, at a dose of 2 mg kg -1 for 6-18 days, caused impaired renal function in animals (Adebayo et al.,
2003 ), Tonica which contains K. senegalensis did not show such an effect, suggesting possible modulating
effect of the other chemical components provided by the other plants contained in Tonica. Furthermore,
morphological studies of the lung did not show any signs of Clara cell and/or alveolar cell damage as a result of
Tonica treatment as shown by other pneumotoxicants like butylated hydroxytoluene, 4-ipomeanol and 1,1-
dichloroethylene (Krijgsheld et al., 1983; Okine et al., 1986; Forkert et al., 1990). These observations are further
supported by the lack of effect of Tonica treatment on the mean wet weight of these organs. Reduction or
increase in size and weight of organs may be a reflection of loss or absorption of water as a result of changes in
osmoregulation due to either tissue damage or changes in osmolality of the ECF (Curtis et al., 1999).
Tonica has been shown to increase the appetite of patients (Adusi-Poku et al., 2008) and this has been
attributed to the presence of Khaya senegalensis in the Tonica extract, which is known to stimulate appetite
(Mshana et al., 2000). This enhanced appetite can lead to increased rate of growth, especially in children.
However, our study showed that Tonica did not significantly affect the growth of the animals. There was also no
evidence of increased intake of food to suggest the enhancement of the appetite of the animals as a result of
Tonica treatment.
Conclusion
These findings show that Tonica is highly tolerated even at 20x the normal dose and that there is no
overt organ specific toxicity associated with it on sub-chronic administration to the rats.
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